RECRUITING

Tobacco Education and Lung Health Study (TEAL)

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Primary Objective To compare two smoking cessation interventions among individuals undergoing lung cancer screening. Primary outcomes are: 3-month self-reported abstinence from cigarettes and 6-month self-reported and bioverified abstinence from cigarettes. Secondary Objectives 1) To evaluate reach and engagement overall and by subgroup (e.g., race and ethnicity, underinsured, readiness to quit). 2) To conduct an economic analysis to evaluate intervention costs from the health system perspective.

Official Title

Providing Tobacco Treatment to Patients Undergoing Lung Cancer Screening at MedStar Health: A Randomized Trial (Tobacco Education and Lung Health Study)

Quick Facts

Study Start:2024-02-22
Study Completion:2026-04
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06290869

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:50 Years to 80 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * eligible for a screening or diagnostic scan,
  2. * USPSTF eligibility criteria (50-80 years old and \>20-pack years);
  3. * currently smoking cigarettes (\>1 in the past 30 days);
  4. * English speaking;
  5. * able to provide meaningful consent.
  1. * prior lung cancer,
  2. * hearing impairment,
  3. * cognitive impairment,
  4. * household member already enrolled.

Contacts and Locations

Study Contact

Kathryn L Taylor, PhD
CONTACT
2022159402
taylorkl@georgetown.edu
Randi M. Williams, PhD
CONTACT
rmw27@georgetown.edu

Study Locations (Sites)

Georgetown University Medical Center
Washington, District of Columbia, 20007
United States

Collaborators and Investigators

Sponsor: Georgetown University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-02-22
Study Completion Date2026-04

Study Record Updates

Study Start Date2024-02-22
Study Completion Date2026-04

Terms related to this study

Keywords Provided by Researchers

  • high risk for lung cancer

Additional Relevant MeSH Terms

  • Smoking Cessation